133 related articles for article (PubMed ID: 17928740)
21. Isolation of JFH-1 strain and development of an HCV infection system.
Wakita T
Methods Mol Biol; 2009; 510():305-27. PubMed ID: 19009271
[TBL] [Abstract][Full Text] [Related]
22. Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.
Jung BK; Kim HR; Park GN; Luo G; Chang KS
J Microbiol; 2016 Jun; 54(6):451-8. PubMed ID: 27225463
[TBL] [Abstract][Full Text] [Related]
23. Cell culture systems for the hepatitis C virus.
Duverlie G; Wychowski C
World J Gastroenterol; 2007 May; 13(17):2442-5. PubMed ID: 17552027
[TBL] [Abstract][Full Text] [Related]
24. Cell Culture Systems of HCV Using JFH-1 and Other Strains.
Wakita T
Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 31501261
[TBL] [Abstract][Full Text] [Related]
25. Valine, the branched-chain amino acid, suppresses hepatitis C virus RNA replication but promotes infectious particle formation.
Ishida H; Kato T; Takehana K; Tatsumi T; Hosui A; Nawa T; Kodama T; Shimizu S; Hikita H; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(1):127-33. PubMed ID: 23806690
[TBL] [Abstract][Full Text] [Related]
26. Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
Aly HH; Qi Y; Atsuzawa K; Usuda N; Takada Y; Mizokami M; Shimotohno K; Hijikata M
Hepatology; 2009 Sep; 50(3):689-96. PubMed ID: 19489071
[TBL] [Abstract][Full Text] [Related]
27. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).
Miyamoto M; Kato T; Date T; Mizokami M; Wakita T
Intervirology; 2006; 49(1-2):37-43. PubMed ID: 16166787
[TBL] [Abstract][Full Text] [Related]
28. Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.
Murayama A; Kato T; Akazawa D; Sugiyama N; Date T; Masaki T; Nakamoto S; Tanaka Y; Mizokami M; Yokosuka O; Nomoto A; Wakita T
J Virol; 2012 Feb; 86(4):2143-52. PubMed ID: 22156532
[TBL] [Abstract][Full Text] [Related]
29. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
30. Advances in hepatitis C: what is coming in the next 5 years?
Locarnini SA; Bartholomeusz A
J Gastroenterol Hepatol; 2002 Apr; 17(4):442-7. PubMed ID: 11982725
[TBL] [Abstract][Full Text] [Related]
31. [Antiviral agents for analyzing virus life cycle: chemical genetics for virology].
Watashi K
Yakugaku Zasshi; 2013; 133(11):1169-75. PubMed ID: 24189558
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
Bartenschlager R
Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
34. Development of hepatitis C virus genotype 3a cell culture system.
Kim S; Date T; Yokokawa H; Kono T; Aizaki H; Maurel P; Gondeau C; Wakita T
Hepatology; 2014 Dec; 60(6):1838-50. PubMed ID: 24797787
[TBL] [Abstract][Full Text] [Related]
35. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
[TBL] [Abstract][Full Text] [Related]
36. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
Kato T; Date T; Miyamoto M; Furusaka A; Tokushige K; Mizokami M; Wakita T
Gastroenterology; 2003 Dec; 125(6):1808-17. PubMed ID: 14724833
[TBL] [Abstract][Full Text] [Related]
37. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus entry.
Zeisel MB; Felmlee DJ; Baumert TF
Curr Top Microbiol Immunol; 2013; 369():87-112. PubMed ID: 23463198
[TBL] [Abstract][Full Text] [Related]
39. Replication studies using genotype 1a subgenomic hepatitis C virus replicons.
Gu B; Gates AT; Isken O; Behrens SE; Sarisky RT
J Virol; 2003 May; 77(9):5352-9. PubMed ID: 12692237
[TBL] [Abstract][Full Text] [Related]
40. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
